#KidneyWk on X 16 hours ago

RT @Neph_Times: SPRINT data show intensive BP control favors most CKD patients, with greatest net benefit in those with lower eGFR. #Kidney…

View Post

#KidneyWk on X 17 hours ago

Myda Khalid, MD, provides important takeaways from the recently published guidelines for #IgANephropathy, touching on data presented at Kidney Week...

View Post

#KidneyWk on X 19 hours ago

SPRINT data show intensive BP control favors most CKD patients, with greatest net benefit in those with lower eGFR. #KidneyWk #nephrology #CKD #hyp...

View Post

#KidneyWk on X 21 hours ago

🎉 Congratulations to AJKD Editor-in-Chief, Harold Feldman, who was presented with the John P. Peters Award at last month's #KidneyWk! https://t.co...

View Post

#KidneyWk on X 21 hours ago

RT @Neph_Times: Harold Feldman receiving the John Peters Award at ASN #KidneyWk. https://t.co/M0Kni6OEVj

View Post

#KidneyWk on X 21 hours ago

RT @ASNKidney: 🎉 Congratulations to Harold I. Feldman, MD, MS, MSc, FASN; Katalin Susztak, MD, PhD; and Rafael Kramann, MD, PhD, FASN for t…

View Post

#KidneyWk on X 21 hours ago

RT @asnpublications: Join us in recognizing the wide-ranging contributions of Harold (Harv) I. Feldman, at #KidneyWk with the presentation…

View Post

#KidneyWk on X 2 days ago

RT @edgarvlermamd: Treatment of Hyponatremia from @NephroMD #Nephpearls #KidneyWk 📌 Use of Hypertonic Saline (HTS) 📌 Management of severe…

View Post

#KidneyWk on X 2 days ago

RT @SBNephrology: Growth looks good on this crew 🫘 @ASNKidney #kidneywk https://t.co/nmadTfHwD3

View Post

#KidneyWk on X 3 days ago

RT @Neph_Times: WATCH Matthew Weir, MD, discussing results from the phase 2 Explore-CKD trial of lorundrostat presented at #KidneyWk. #neph…

View Post